1 | than | 178,393 |
2 | breasted | 2 |
3 | calorie-tpn | 2 |
4 | co-flexibility | 2 |
5 | prononced | 2 |
6 | .about | 1 |
7 | .approximately | 1 |
8 | 12α-hydroxy/non-12α-hydroxy | 1 |
9 | 3-hydroxyl-3-methylglutaryl-coenzyme | 1 |
10 | adults.to | 1 |
11 | benefit.biweekly | 1 |
12 | body-volume | 1 |
13 | brachial-aortic | 1 |
14 | bronchodialtor | 1 |
15 | clear.high-dose | 1 |
16 | coldly | 1 |
17 | compliance.in | 1 |
18 | datafor | 1 |
19 | diazafulvenium | 1 |
20 | dicolofenac | 1 |
21 | discontentedness | 1 |
22 | distally-tapering | 1 |
23 | dose-while | 1 |
24 | ffls | 1 |
25 | fluoxetine-than | 1 |
26 | fully.for | 1 |
27 | gsk-sponsored | 1 |
28 | haloperidol-reduced | 1 |
29 | hyperaminoacidaemia | 1 |
30 | isolation-rates | 1 |
31 | loureirins | 1 |
32 | marked.sildenafil | 1 |
33 | mortality-rates | 1 |
34 | na-reabsorption | 1 |
35 | nadh/nadph-driven | 1 |
36 | nonmercurial | 1 |
37 | physical-as | 1 |
38 | propofol-lower | 1 |
39 | ptss-level | 1 |
40 | quadruplicated | 1 |
41 | r2*s | 1 |
42 | risk.although | 1 |
43 | rocedure | 1 |
44 | rolloff | 1 |
45 | serosanguinous | 1 |
46 | than.10 | 1 |
47 | thant | 1 |
1 | .about | 1 |
2 | .approximately | 1 |
3 | 12α-hydroxy/non-12α-hydroxy | 1 |
4 | 3-hydroxyl-3-methylglutaryl-coenzyme | 1 |
5 | adults.to | 1 |
6 | benefit.biweekly | 1 |
7 | body-volume | 1 |
8 | brachial-aortic | 1 |
9 | breasted | 2 |
10 | bronchodialtor | 1 |
11 | calorie-tpn | 2 |
12 | clear.high-dose | 1 |
13 | co-flexibility | 2 |
14 | coldly | 1 |
15 | compliance.in | 1 |
16 | datafor | 1 |
17 | diazafulvenium | 1 |
18 | dicolofenac | 1 |
19 | discontentedness | 1 |
20 | distally-tapering | 1 |
21 | dose-while | 1 |
22 | ffls | 1 |
23 | fluoxetine-than | 1 |
24 | fully.for | 1 |
25 | gsk-sponsored | 1 |
26 | haloperidol-reduced | 1 |
27 | hyperaminoacidaemia | 1 |
28 | isolation-rates | 1 |
29 | loureirins | 1 |
30 | marked.sildenafil | 1 |
31 | mortality-rates | 1 |
32 | na-reabsorption | 1 |
33 | nadh/nadph-driven | 1 |
34 | nonmercurial | 1 |
35 | physical-as | 1 |
36 | prononced | 2 |
37 | propofol-lower | 1 |
38 | ptss-level | 1 |
39 | quadruplicated | 1 |
40 | r2*s | 1 |
41 | risk.although | 1 |
42 | rocedure | 1 |
43 | rolloff | 1 |
44 | serosanguinous | 1 |
45 | than | 178,393 |
46 | than.10 | 1 |
47 | thant | 1 |
1 | than.10 | 1 |
2 | hyperaminoacidaemia | 1 |
3 | dicolofenac | 1 |
4 | brachial-aortic | 1 |
5 | prononced | 2 |
6 | haloperidol-reduced | 1 |
7 | gsk-sponsored | 1 |
8 | quadruplicated | 1 |
9 | breasted | 2 |
10 | dose-while | 1 |
11 | body-volume | 1 |
12 | 3-hydroxyl-3-methylglutaryl-coenzyme | 1 |
13 | rocedure | 1 |
14 | clear.high-dose | 1 |
15 | rolloff | 1 |
16 | distally-tapering | 1 |
17 | risk.although | 1 |
18 | nonmercurial | 1 |
19 | ptss-level | 1 |
20 | marked.sildenafil | 1 |
21 | diazafulvenium | 1 |
22 | than | 178,393 |
23 | fluoxetine-than | 1 |
24 | nadh/nadph-driven | 1 |
25 | compliance.in | 1 |
26 | na-reabsorption | 1 |
27 | calorie-tpn | 2 |
28 | adults.to | 1 |
29 | propofol-lower | 1 |
30 | fully.for | 1 |
31 | datafor | 1 |
32 | bronchodialtor | 1 |
33 | r2*s | 1 |
34 | physical-as | 1 |
35 | isolation-rates | 1 |
36 | mortality-rates | 1 |
37 | ffls | 1 |
38 | loureirins | 1 |
39 | discontentedness | 1 |
40 | serosanguinous | 1 |
41 | thant | 1 |
42 | .about | 1 |
43 | coldly | 1 |
44 | .approximately | 1 |
45 | benefit.biweekly | 1 |
46 | co-flexibility | 2 |
47 | 12α-hydroxy/non-12α-hydroxy | 1 |